Amneal Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segm…

Drug Manufacturers - Specialty & Generic
US, Bridgewater [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Amneal Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of AMRX's Analysis
CIK: 1723128 CUSIP: 03168L105 ISIN: US03168L1052 LEI: - UEI: -
Secondary Listings
AMRX has no secondary listings inside our databases.